Sigal Russo, CFO
Sigal Russo is a seasoned professional financial leader, bringing over 16 years of experience in key managerial positions in global, public Biotech and Pharmaceutical companies as well as in early-stage start-up companies, having previously worked for Mobilicom Ltd (ASX: MOB), OWC Pharmaceutical Research Corp. (OTCQB: OWCP) and Rosetta Genomics (NASDAQ: ROSG). Ms. Russo was also an audit manager at Ernst & Young in Israel, specializing in audits of companies from various sectors, from 2004 to 2008. Ms. Russo holds a BA in Economics and Accounting, from the Ruppin Academic College.
Tal Ben Neriah, VP Operations
Tal holds a MSc. in Materials Engineering and Nanotechnology and a BSc. in Life and Medical Sciences, both from Tel Aviv University.
Tal worked for more than eight years at CollPlant (NASDAQ: CLGN), a medical device company focused on regenerative medicine, as product development engineer, project manager and program manager.
Tal led multidisciplinary activities from early development to regulatory approval including clinical phase of the company’s two commercial products and we are sure that Tal will help us achieve our research and development goals.
Tamar Harel Adar, PhD – VP R&D
Tamar Harel Adar, PhD brings years of experience in Biotechnology, having previously worked for CollPlant biotechnology (NASDAQ: CLGN) and Cellect Biotherapeutics (NASDAQ: APOP). Tamar has completed her Biotechnology Engineering doctoral studies at Ben Gurion University of the Negev.
Alon Sinai – Co-Founder & CEO
Alon Sinai brings over 25 years of operational and managerial experience in medical corps of the Israeli Defense Forces. He holds a Master’s degree in Health Systems Management and a Bachelor’s degree in emergency medicine.
Prof. Tal Dvir, PhD – Co-Founder & CSO
Professor Dvir obtained his Ph.D. in Biotechnology Engineering from Ben Gurion University of the Negev in Israel. His Ph.D. research focused on cardiac tissue engineering and regeneration. Prof. Dvir continued his postdoctoral studies in the laboratory of Professor Robert Langer in the Department of Chemical Engineering at MIT. His postdoctorial research focused on nanotechnological strategies for engineering complex tissues. In 2011, Professor Dvir was recruited by the Department of Biotechnology and the center for Nanotechnology at Tel Aviv University to establish the Laboratory for Tissue Engineering and Regenerative Medicine. In 2013, he joined the newly established Department of Materials Science and Engineering at Tel Aviv University, where he has also served as an Associate Professor in the Department of Biotechnology since 2015.